<img alt="" src="https://secure.inventiveperception365.com/789096.png" style="display:none;">

Rapid Enumeration of Bioburden in a Model Sample Matrix for Influenza Vaccine Using the Growth Direct™ System

This informative study demonstrates that Growth Direct analyzes microbial contaminants in egg white, a model matrix for allantoic fluid, more rapidly than traditional culture methods—up to 50% faster. The time savings, combined with lower labor costs and improved compliance, can result in:

  • Significantly lower manufacturing costs, by reducing hold times between manufacturing steps and speeding release of product
  • Personnel who are free to perform higher-value tasks
  • Reduced product scrap by shortening response times to microbial contamination
  • Improved overall QC, QA, and manufacturing efficiency
  • Potential payback on the initial investment of the Growth Direct System within two years or less

Fill out the form to get your copy today.